Cargando…
Barrier effect of Esoxx(®) on esophageal mucosal damage: experimental study on ex-vivo swine model
The aim of the present study was to assess the potential barrier effect of Esoxx(®), a new nonprescription medication under development for the relief of gastroesophageal reflux symptoms. Esoxx is based on a mixture of hyaluronic acid and chondroitin sulfate in a bioadhesive suspension of Lutrol(®)...
Autores principales: | Di Simone, Massimo P, Baldi, Fabio, Vasina, Valentina, Scorrano, Fabrizio, Bacci, Maria Laura, Ferrieri, Antonella, Poggioli, Gilberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387832/ https://www.ncbi.nlm.nih.gov/pubmed/22767997 http://dx.doi.org/10.2147/CEG.S31404 |
Ejemplares similares
-
Barrier Effect of a New Topical Agent on Damaged Esophageal Mucosa: Experimental Study on an ex vivo Swine Model
por: Salaroli, Roberta, et al.
Publicado: (2020) -
Esoxx added to standard therapy accelerates the healing of esophagitis
por: Pietrzak, Anna Maria
Publicado: (2023) -
Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non‐erosive reflux disease – efficacy of Esoxx, a hyaluronic acid–chondroitin sulphate based bioadhesive formulation
por: Savarino, V., et al.
Publicado: (2017) -
A novel ex vivo porcine model of acid-induced esophageal damage for preliminary functional evaluations of anti-gastroesophageal reflux disease medical devices
por: Ventrella, Domenico, et al.
Publicado: (2020) -
Exploration of the Esophageal Mucosal Barrier in Non-Erosive Reflux Disease
por: Rinsma, Nicolaas F., et al.
Publicado: (2017)